643 results on '"Bihrle, Richard"'
Search Results
2. Ileal Ureter Utilization in Patients With Previous Urinary Diversions
3. A Prospective Program to Reduce the Clinical Incidence of Clostridium Difficile Colitis Infection after Cystectomy
4. Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant Chemotherapy
5. Primary Choriocarcinoma of the Bladder: A Case Report and Review of Literature
6. Long term outcomes in the use of ileal ureter for radiation-induced ureteral strictures
7. Supplementary Figure Legend from A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157
8. Does Squamous Differentiation Portend Worse Outcomes in Urothelial Bladder Cancer?
9. Short-term morbidity and mortality of Indiana pouch, ileal conduit, and neobladder urinary diversion following radical cystectomy
10. Survival Analysis of Pure Seminoma at Post-Chemotherapy Retroperitoneal Lymph Node Dissection
11. Critical analysis of the 2010 TNM classification in patients with lymph node–positive bladder cancer: Influence of lymph node disease burden
12. Plasmacytoid variant urothelial bladder cancer: Is it time to update the treatment paradigm?
13. Reoperative Retroperitoneal Lymph Node Dissection for Metastatic Germ Cell Tumors: Analysis of Local Recurrence and Predictors of Survival
14. Early and Midterm Complications of the Continent Catheterizable Indiana Pouch Urinary Diversion: A 7-year Experience
15. Serum tumor markers in testicular cancer
16. ADJUSTED CLINICAL OUTCOMES IN PATIENTS WITH SARCOMATOID VARIANT UROTHELIAL CARCINOMA UNDERGOING RADICAL CYSTECTOMY FOR MUSCLE INVASIVE DISEASE: PD33-03
17. EMPIRIC TREATMENT OF IDENTIFIED CLOSTRIDIUM DIFFICILE CARRIERS AT TIME OF CYSTECTOMY: PRELIMINARY OUTCOMES: MP56-02
18. A STUDY TO EVALUATE THE PROGNOSTIC AND PREDICTIVE UTILITY OF CCP AND HRD ASSAYS AND GENETIC SEQUENCING IN PATIENTS UNDERGOING NEOADJUVANT CHEMOTHERAPY IN BLADDER CANCER: MP49-02
19. LONG-TERM 10-YEAR HEALTH-RELATED QUALITY OF LIFE OUTCOMES FOLLOWING RADICAL CYSTECTOMY: MP38-13
20. Evolving concepts in surgical management of testis cancer
21. The changing reality of urothelial bladder cancer: should non-squamous variant histology be managed as a distinct clinical entity?
22. MP65-14 INCIDENCE AND RISK FOR CLOSTRIDIUM DIFFICILE INFECTIOUS COLITIS IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER
23. MP64-17 LACK OF IMPROVEMENT IN RADICAL CYSTECTOMY OUTCOMES OVER 20 YEARS?
24. MP58-11 DOES SQUAMOUS DIFFERENTIATION PORTEND WORSE OUTCOMES IN UROTHELIAL BLADDER CANCER?
25. MP29-11 URETERAL RECONSTRUCTION WITH ILEUM: LONG TERM FOLLOW-UP OF RENAL FUNCTION
26. MP29-12 USE OF THE ILEAL URETER FOR RADIATION-INDUCED URETERAL STRICTURES
27. MP10-17 MANAGEMENT OF CHYLOUS LEAK AFTER RETROPERITONEAL LYMPH NODE DISSECTION FOR ADVANCED TESTICULAR CANCER
28. MP10-08 MODIFIED TEMPLATE RETROPERITONEAL LYMPH NODE DISSECTION FOR POSTCHEMOTHERAPY RESIDUAL TUMOR: A LONG TERM UPDATE
29. Long-Term Outcome for Patients With High Volume Retroperitoneal Teratoma Undergoing Post-Chemotherapy Surgery
30. Delayed Orchiectomy at Postchemotherapy Retroperitoneal Lymph Node Dissection Due to Laterality of Retroperitoneal Metastatic Pattern Consistent with Testicular Primary: Assessment of Pathologic Findings
31. Incidence and Risk Factors of Parastomal Hernia in Patients Undergoing Radical Cystectomy and Ileal Conduit Diversion
32. CAN LYMPHOVASCULAR INVASION BE USED AS A SURROGATE FOR LYMPH NODE INVOLVEMENT IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA?: MP77-18
33. PROPOSED NODAL STAGING CLASSIFICATION IN UROTHELIAL CARCINOMA OF THE BLADDER BASED ON BURDEN OF LYMPH LODE INVOLVEMENT: MP65-17
34. EFFICACY OF NEOADJUVANT CHEMOTHERAPY IN BLADDER CANCER: MP55-19
35. SIGNIFICANCE OF LYMPH NODE INVOLVEMENT IN VARIANT HISTOLOGY UROTHELIAL BLADDER CANCER: MP55-07
36. SURGICAL MANAGEMENT OF RETROCRURAL DISEASE IN TESTIS CANCER: OUTCOMES AND EVOLUTION OF PRACTICE: PD5-05
37. Ventral onlay buccal mucosa urethroplasty: A 10-year experience
38. Longitudinal Health Related Quality of Life After Open Radical Cystectomy: Comparison of Ileal Conduit, Indiana Pouch, and Orthotopic Neobladder
39. Contemporary bladder cancer: Variant histology may be a significant driver of disease
40. Lymph node metastases in patients with urothelial carcinoma variants: Influence of the specific variant on nodal histology
41. Significance of Primary Tumor Size and Preorchiectomy Serum Tumor Marker Level in Predicting Pathologic Stage at Retroperitoneal Lymph Node Dissection in Clinical Stage A Nonseminomatous Germ Cell Tumors
42. Post Chemotherapy RPLND in Patients with Elevated Markers: Current Concepts and Clinical Outcome
43. Does the Presence of Extranodal Extension in Pathological Stage B1 Nonseminomatous Germ Cell Tumor Necessitate Adjuvant Chemotherapy?
44. Surgical Management of Retrocrural Disease in Germ Cell Tumors: Outcomes and Evolution of Practice
45. Secondary surgery in germ cell tumors—when and how extensively should it be performed?
46. Incidence, Histology and Management of Intraluminal Thrombus at Post-Chemotherapy Retroperitoneal Lymph Node Dissection
47. CLINICAL AND PATHOLOGIC OUTCOMES OF TESTIS CANCER PATIENTS UNDERGOING REDO POST CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION: 707
48. Clinical and Pathological Features Predictive of Nephrectomy at Post-Chemotherapy Retroperitoneal Lymph Node Dissection
49. Percutaneous Imaging-Guided Access for the Treatment of Calculi in Continent Urinary Reservoirs
50. LATE RECURRENCE IN PATIENTS WITH HISTORY OF COMPLETE REMISSION OF METASTATIC GERM CELL TUMORS TO CHEMOTHERAPY: 665
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.